Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Astria Therapeutics Inc | ATXS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
9.02 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 4.26 - 16.90 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 9.02 | USD |
Astria Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
468.87M | 54.90M | - | 0 | -72.89M | -1.33 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Astria Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATXS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.51 | 9.73 | 8.91 | 9.09 | 473,638 | -0.49 | -5.15% |
1 Month | 9.15 | 10.37 | 8.91 | 9.49 | 618,681 | -0.13 | -1.42% |
3 Months | 13.71 | 16.90 | 8.77 | 12.58 | 1,016,515 | -4.69 | -34.21% |
6 Months | 4.70 | 16.90 | 4.50 | 11.35 | 868,068 | 4.32 | 91.91% |
1 Year | 11.00 | 16.90 | 4.26 | 10.65 | 546,213 | -1.98 | -18.00% |
3 Years | 8.53 | 16.90 | 2.36 | 10.40 | 276,953 | 0.49 | 5.74% |
5 Years | 8.53 | 16.90 | 2.36 | 10.40 | 276,953 | 0.49 | 5.74% |
Astria Therapeutics Description
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. |